Online Courses for Pharmacist

A complete listing of currently available online programs is provided below. To access course materials and claim credit you must be registered and logged-in. Courses of interest must be selected and added to your FCMCME.org user account. Once selected course material links will be provided from within your individual User Record section of this website.

Sort by: Title | Newest
Case Studies In Heart Failure
Presented by: Nicholas D. Wyatt, PharmD, Peter J. Kudenchuk, MD
Effective Date: February 01, 2017
Expiration Date: March 01, 2020
Credits: 2.5
Format: Webinar
Fee: $60.00
16748

Heart failure impacts the lives of thousands upon thousands of patients as well as their family members every year. The disease cost the healthcare system billions of dollars every year and is expected to continue to rise.

This course will give the participant the resources and tools necessary to become a heart failure expert. Our discussion will start with the epidemiology of heart failure. Then we will transition into discussing the stages of heart failure, specifically focusing on the four stages of heart failure and the evidence treatments of these four stages. Thanking you for joining me on your journey to becoming a heart failure expert. Let' get started.

Outcome Objectives
Upon completion of this CME/CE activity the healthcare provider will be able to:

  1. Describe the clinical epidemiology of heart failure and its impact on health care delivery and costs.
  2. List the modifiable risk factors of heart failure
  3. Identify the non-modifiable risk factors of heart failure
  4. Describe the population attribution risk of heart failure for modifiable and non-modifiable risk factors
  5. Define the four stages of the ACC/AHA heart failure staging model.
  6. Describe the four classification stages of the NYHA heart failure staging model.
  7. Describe the neurohormonal response in patients with and without heart failure.
  8. Identify key compensatory neurohormones in heart failure patients.
  9. Describe the renin-angiotension system response in patients with heart failure.
  10. List the compensatory responses that maintain circulation as a result of decreased cardiac output.
  11. Name two biomarkers used in the diagnosis and assessment heart failure.
  12. Discuss the four components of examining the heart failure patient.

To participate in this activity you must be Registered and Logged In to this website.

Selection Required to View & Claim Credit

Nitric Oxide Therapeutic Intervention: Bridging the Gap Between Microvascular Dysfunction and Cognitive Impairment
Presented by: Nathan S. Bryan, Ph.D
Effective Date: September 01, 2019
Expiration Date: August 31, 2021
Credits: 1.0
Format: Webinar
Fee: $30.00
17999

In this presentation, Nathan S. Bryan will provide an overview of the atmospheric and human nitrogen cycles and nitric oxide production pathways in humans. He will review evidence based nitric oxide research specific to vascular function and structure. In addition to nitric oxide production, he will review the importance of nitrate and how much is recommended daily for health benefits. Dr. Bryan will also discuss nitric oxide therapeutic interventional outcome data and how to control and regulate nitric oxide production

Outcome Objectives
Upon completion of this CME activity the healthcare provider will be able to:

  1. Recognize nitric oxide production pathways in humans.
  2. Demonstrate evidence on how NO affects vascular structure and function.
  3. Communicate evidence based nutritional strategies to restore and replete NO production in humans to restore vascular structure and function.

Selection Required to View & Claim Credit

Opioid Addiction: Challenging Cases in Diagnosis, Treatment, and Prevention
Presented by: Christine Mintz, MD
Effective Date: June 19, 2018
Expiration Date: June 19, 2020
Credits: 1.0
Format: Webinar
Fee: $15.00
17298

It is estimated that each day more than 1000 people are treated in emergency departments for not using prescription opioids as prescribed. Combine this with illicit drug use and the cost of treatment and productivity losses related to addiction and we have a current epidemic costing Americans over 500 billion dollars and rising.

This interactive course will give the participant the resources and tools necessary to identify, educate and treat opioid tolerant and opioid addicted patients in primary care. We will cover the pathophysiology of opioids and their receptors, then we will transition to discussing tolerance vs. withdrawal and addiction. We will also review overdose antagonist medications, medication assisted treatments as well as briefly discuss new treatments and research on the horizon.

Outcome Objectives:
Upon completion of this CME/CE activity the healthcare provider will be able to:

  1. Describe the pathophysiology of opioid receptors in the dopamine reward pathway and how different opioids and opioid antagonists interact and bind to these receptors.
  2. Describe the common clinical features of chronic opioid abuse and suspected opioid withdrawal including appropriate diagnostic work-up.
  3. Discuss the current best practice treatment options for suspected opioid overdose including routes of administration and formulations as well as medication assisted treatment options.
  4. Identify new or emerging areas of research and treatment options for opioid dependence including pharmacologic and psychosocial strategies.

To fully participate in this activity you must be Registered and Logged In to this website.

Selection Required to View & Claim Credit

Reversal of Cognitive Decline: The Science, The Tools, and The Transformation
Presented by: Kenneth S. Sharlin, M.D., M.P.H., IFMCP
Effective Date: August 01, 2019
Expiration Date: August 01, 2021
Credits: 1.0
Format: Webinar
Fee: $20.00
17940

This presentation will address the burden of Alzheimer’s disease in the United States and the role of amyloid beta in the progression of this disease. You will be given the tools to help prevent Alzheimer’s disease through lifestyle medicine and modification.

Outcome Objectives
Upon completion of this CME activity the healthcare provider will be able to:

  1. Outline the burden of Alzheimer’s disease in the United States.
  2. Describe the role that the lipid-binding protein APoE4 plays in modifying the risk of Alzheimer’s disease.
  3. List at least two normal roles for amyloid beta in the brain.
  4. Describe the solutions lifestyle medicine provides to address the burden of Alzheimer’s disease.

Selection Required to View & Claim Credit